Galactose mutarotase catalyzes the conversion of ␤-Dgalactose to ␣-D-galactose during normal galactose metabolism. The enzyme has been isolated from bacteria, plants, and animals and is present in the cytoplasm of most cells. Here we report the x-ray crystallographic analysis of human galactose mutarotase both in the apoform and complexed with its substrate, ␤-D-galactose. The polypeptide chain folds into an intricate array of 29 ␤-strands, 25 classical reverse turns, and 2 small ␣-helices. There are two cis-peptide bonds at Arg-78 and Pro-103. The sugar ligand sits in a shallow cleft and is surrounded by Asn-81, Arg-82, His-107, His-176, Asp-243, Gln-279, and Glu-307. Both the side chains of Glu-307 and His-176 are in the proper location to act as a catalytic base and a catalytic acid, respectively. These residues are absolutely conserved among galactose mutarotases. To date, x-ray models for three mutarotases have now been reported, namely that described here and those from Lactococcus lactis and Caenorhabditis elegans. The molecular architectures of these enzymes differ primarily in the loop regions connecting the first two ␤-strands. In the human protein, there are six extra residues in the loop compared with the bacterial protein for an approximate longer length of 9 Å. In the C. elegans protein, the first 17 residues are missing, thereby reducing the total number of ␤-strands by one.
Mutations in three of the enzymes of the Leloir pathway, namely galactokinase, galactose 1-phosphate uridylyltransferase, or UDP-galactose 4-epimerase, have been demonstrated to result in the diseased state known as galactosemia (2, 3) . The symptoms of this genetic disease include early onset cataracts (typically within the first two years of life) and, in more severe cases, liver, kidney, and brain damage. Cataract formation is believed to be caused by the buildup of unmetabolized galactose in the lens of the eye. Aldose reductase catalyzes the reduction of the sugar to galactitol (dulcitol), which is not, in contrast to galactose, readily transported across the plasma membrane (4 -6) . As such, the accumulation of this highly osmotically active compound draws excess water into the lens resulting in cataracts by a mechanism that is not fully understood. The more severe symptoms of galactosemia are most likely caused by a combination of these osmotic effects and the accumulation of the intermediate ␣-D-galactose-1-phosphate (7) , although the precise mechanism of toxicity is not understood. No known disease-causing mutations in human galactose mutarotase have been identified thus far. However, galactitol is reported to be an inhibitor of mammalian mutarotase (8) , raising the possibility that its accumulation would partly block the action of mutarotase, resulting in a further buildup of unmetabolized galactose.
Galactose mutarotase activity was first reported in Escherichia coli in 1965 (9) and has since been observed in a wide range of organisms, including bacteria (9 -16) , plants (17, 18) , fungi (19) , and mammals (20 -23) . It is present in the cytoplasm of most cells, suggesting that the in vivo rate of uncatalyzed mutarotation is insufficient for the metabolic needs of the organism. Indeed, deletion of the mutarotase gene from E. coli results in slow growth on minimal medium containing phenyl-␤-D-galactopyranose as the sole carbon source (11) .
The first three-dimensional structure of a dimeric mutarotase, namely that from Lactococcus lactis, was reported in 2002 (24) . The enzyme was shown to adopt a ␤-sandwich motif, similar to that seen in domain 5 of ␤-galactosidase (25) with the sugar binding site located in a wide, shallow cleft. Five highly conserved residues (Arg-71, His-96, His-170, Asp-243, and Glu-304) were within hydrogen-bonding distance to the hydroxyl groups of the bound galactose ligand. Previous kinetic studies suggested that the reaction mechanism for the enzyme proceeds via an acid/base mechanism with a transient ring opening (26, 27) , and the model of the mutarotase from L. lactis implicated Glu-304 as the likely catalytic base and either His-96 or His-170 as the catalytic acid (24) . Accordingly, the reaction mechanism of galactose mutarotase is thought to occur via abstraction of the proton from the C-1 hydroxyl group by Glu-304 in the L. lactis enzyme and protonation of the ring oxygen of the sugar by His-170, which results in ring opening. Subsequent rotation about the C-1-C-2 bond followed by a reversal of the ring opening events ultimately yields a product with an altered configuration at C-1 (28) . Site-directed mutagenesis of these residues (or their equivalents in the E. coli enzyme) have confirmed the role of Glu-304 as the catalytic base and established His-170 as the catalytic acid (28, 29) .
The gene encoding the human enzyme was identified in 2003, and the protein product was characterized (30) . From these investigations, it was suggested that Glu-307 and His-176 fulfill the roles in acid/base catalysis in the human mutarotase (30) . Interestingly, regardless of the source, mutarotases tend to show a preference for galactose over glucose and have high k cat and K m values with this sugar (typically 10 4 Ϫ 10 5 s
Ϫ1
and 10 Ϫ 100 mM, respectively) (23, 30 -33) . The preference of these enzymes for galactose over glucose was addressed structurally with the L. lactis mutarotase and, at least in the case of this bacterial protein, is explained by the existence of nonproductive binding modes in the active site for glucose and its derivatives (33) . With respect to quaternary structure, human mutarotase appears to be monomeric (10, 30) , whereas the L. lactis enzyme was shown to be a dimer on the basis of ultracentrifugation experiments (24) . The biochemical significance, if any, of these differences in quaternary structure is not understood at the present time.
Here we describe the three-dimensional structure of human galactose mutarotase, both in the unbound state and complexed with its substrate, ␤-D-galactose. This study represents the first report of a eukaryotic mutarotase with bound sugar and allows for a detailed comparison between the human and the bacterial forms of the enzyme.
EXPERIMENTAL PROCEDURES
Cloning of the Galactose Mutarotase Gene-The human galactose mutarotase gene was amplified from the originally described pET21-GALM plasmid (30) using a forward primer designed with an NdeI restriction site at the start codon and a reverse primer with a XhoI restriction site after the stop codon. This construct allowed for insertion of the PCR product into the pTYB12 expression vector, which provides an N-terminal chitin-binding domain followed by a dithiothreitol-inducible intein (New England Biolabs). The recloning was done because diffraction-quality crystals could not be obtained with protein expressed from the pET21-GALM plasmid construct, which contained a noncleavable N-terminal polyhistidine tag.
Protein Expression and Purification-For protein expression, the pTYB12-GALM plasmid was used to transform E. coli HMS174(DE3) cells (Novagen). A starter culture from a single colony was grown overnight at 37°C in LB medium supplemented with ampicillin. Subsequently, 10 ml were transferred to 1000 ml of the supplemented LB medium in a 2-liter shaker flask and grown at 37°C until an optical density of 0.8 was achieved at 600 nm. The cultures were cooled to 16°C in an ice-water bath, and IPTG 1 was added to a final concentration of 1 mM. Cell growth was allowed to continue at 16°C for an additional 15 h.
The cells were harvested by centrifugation at 4,000 ϫ g for 15 min and frozen in liquid nitrogen. Frozen cells (50 g) were thawed in 150 ml of lysis buffer consisting of 20 mM NaH 2 PO 4 and 500 mM NaCl (pH 8.0). The thawed cells were placed in an ice bath and disrupted by four rounds of sonication (1-min duration each) separated by 5 min of cooling. Cellular debris was removed by centrifugation at 20,000 ϫ g for 25 min. The clarified supernatant was loaded onto a 100-ml column of chitin beads (New England Biolabs) that had been equilibrated previously with lysis buffer. The column was then washed with lysis buffer until the absorbance reading at 280 nm reached background level. The column was charged by washing with 200 ml of lysis buffer augmented with 100 mM dithiothreitol. The charged column was subsequently moved to room temperature, allowed to stand for 18 h, and then returned to 4°C. The cleaved protein was eluted with lysis buffer. Pro-tein-containing fractions were pooled based on purity, as judged by SDS-PAGE, and dialyzed against 10 mM HEPES and 200 mM NaCl (pH 7.5). The dialyzed protein was concentrated to 23.0 mg/ml based on the extinction coefficient of 0.85 ml⅐mg Ϫ1 ⅐cm Ϫ1 as calculated with the program Protean (DNASTAR, Inc., Madison, WI). A typical yield was between 80 and 100 mg of protein/50 grams of cells.
Crystallization of Apogalactose Mutarotase-A search for crystallization conditions was conducted both at room temperature and at 4°C via the hanging drop method of vapor diffusion utilizing an in-house-designed sparse matrix screen composed of 144 conditions. The best crystals were observed growing at 4°C from polyethylene glycol 8000 (PEG-8000) at pH 5.0. Large single crystals were subsequently obtained by seeding into batch experiments with precipitant solutions of 5-8% PEG-8000 buffered with 100 mM Homopipes (pH 5.0) and enzyme concentrations of 12 mg/ml. Diamond-shaped crystals grew to maximum dimensions of ϳ0.5 ϫ 0.3 ϫ 0.1 mm in 3-5 weeks. They belonged to the space group P2 1 with unit cell dimensions of a ϭ 60.7 Å, b ϭ 90.7 Å, c ϭ 70.0 Å, and ␤ ϭ 102.5°. The asymmetric unit contained two monomers.
Structural Analysis of Apogalactose Mutarotase-An x-ray data set was collected to 2.2 Å resolution at 4°C with a Bruker HISTAR area detector system equipped with Supper "long" mirrors. The x-ray source was CuK ␣ radiation from a Rigaku RU200 x-ray generator operated at 50 kV and 90 mA. The x-ray data were processed with XDS (34, 35) and internally scaled with XSCALIBRE.
2 X-ray data collection statistics are presented in Table I . The structure was solved by molecular replacement with the program AMORE (36) and using, as a search model, one subunit of the L. lactis enzyme (Protein Data Bank accession number 1L7J). Two peaks were readily identified in the rotation search. A subsequent translation search and rigid body refinement to 3.0 Å yielded an R-factor of 46%. To reduce model bias, the electron densities corresponding to the two monomers in the asymmetric unit were averaged with the software package AVE (37, 38) . From this averaged electron density map, a model for the complete monomer was constructed and then placed back into the unit cell for subsequent least squares refinement with TNT (39) . Alternate cycles of manual rebuilding and least square refinement reduced the R-factor to 17.4% for all measured x-ray data to 2.2 Å resolution. Refinement statistics are presented in Table II .
Structural Analysis of Galactose Mutarotase Complexed with ␤-DGalactose-Apogalactose mutarotase crystals were harvested from batch experiments and equilibrated in a synthetic mother liquor composed of 10% PEG-8000, 200 mM NaCl, 100 mM Homopipes (pH 5.0), and 100 mM D-galactose in an attempt to soak the sugar into the crystalline lattice. This, however, led to cracking of the crystals and a marked change in lattice parameters and x-ray diffraction quality. Following these initial soaking experiments, crystals were grown by seeding into batch experiments with precipitant solutions of 5-8% PEG-8000 buffered with 100 mM MES (pH 6.0), 200 mM LiCl, and 100 mM D-galactose with enzyme concentrations of 12.0 mg/ml. The crystals of the apoenzyme were used for initial nucleation. Rod-like crystals appeared after 3-4 weeks and achieved maximum dimensions of ϳ0.5 ϫ 0.2 ϫ 0.1 mm. They belonged to the space group P1 with unit cell dimensions of a ϭ 61.0 Å, b ϭ 68.7 Å, c ϭ 98.9 Å, ␣ ϭ 107.7°, ␤ ϭ 98.4°, and ␥ ϭ 102.7°and contained four monomers in the asymmetric unit. Most likely the initial attempts at soaking crystals of space group P2 1 in solutions containing galactose resulted in a change of space group, thereby leading to the observed deterioration in the quality of the x-ray diffraction properties.
An x-ray data set from a crystal of the enzyme-sugar complex was collected to 2.3 Å resolution at 4°C, processed with SAINT (Bruker AXS, Inc.), and scaled as described previously. This protein-substrate complex structure was solved via molecular replacement with the software package AMORE (36) and employing, as the search model, the x-ray coordinates for the apoenzyme. Iterative cycles of least square refinement with TNT (39) and manual manipulation with TURBO (40) reduced the R-factor to 16.9% for all observed data from 30.0 to 2.30 Å resolution. Refinement statistics are presented in Table II .
Quality of the X-ray Models-The models for both the apo-and sugar-bound forms of human galactose mutarotase refined to low Rfactors with excellent overall stereochemistry as indicated in Table II . Electron density was visible for all of the polypeptide chains (Met-1 to Ala-342) in the asymmetric unit, regardless of the space group. In several of the monomers, the Gly-His motifs left behind from the intein construct were visible. Only the polypeptide chain backbone from Lys-249 to Lys-252 was somewhat weaker in each monomer. A Ramachandran plot reveals only one significant outlier in either the apoenzyme or the protein/galactose monomers, namely Asn-81 with average , angles of 70°and Ϫ159°, respectively. The electron density corresponding to Asn-81 is unequivocal in each monomer, and, in fact, its side chain carboxamide group forms a hydrogen bond with the 2-hydroxyl group of bound ␤-D-galactose. This strained conformation is not a function of sugar binding because it is also observed in the apoenzyme model. Shown in Fig. 1 is the electron density corresponding to one of the ␤-D-galactose moieties in the P1 asymmetric unit. Each of the four 2 I. Rayment and G. Wesenberg, unpublished data. sugars in the asymmetric unit was modeled into the electron density map in the ␤-anomeric configuration. Excluding the C-6 hydroxyl oxygens, the average B-values for the sugars are between 31.0 and 39.4 Å 2 . The C-6 hydroxyl oxygens refined to high B-values of 77.1, 89.3, 100, and 100 Å 2 . These higher temperature factors most likely reflect the fact that there are no direct hydrogen-bonding interactions between the protein and this portion of the substrate.
RESULTS AND DISCUSSION
Crystals of the apo-form of galactose mutarotase belong to the space group P2 1 with two polypeptide chains per asymmetric unit. The ␣-carbons for these two monomers superimpose with an r.m.s.d. of 0.17 Å and, as such, are essentially identical within experimental error. Hence, for the sake of simplicity, the following discussion will only refer to monomer I in the x-ray coordinate file. The chitin-binding domain/intein construct employed for protein expression and purification left a residual glycine and a histidine residue at the N terminus. These two residues are well ordered in monomer I but are not visible in the electron density for monomer II.
Shown in Fig. 2a is a ribbon representation of the monomeric human enzyme, which has the overall dimensions of ϳ60 ϫ 40 ϫ 55 Å. The polypeptide chain folds into a complicated series of 29 ␤-strands ranging in length from 2 to 11 amino acid residues. These strands are connected by a number of classical reverse turns including 12 type I, 4 type IЈ, 6 type II, 1 type IIЈ, 1 type III, and 1 type IIIЈ. There are two ␣-helical regions defined by Leu-62 to Leu-66 and Leu-230 to Leu-234. cisPeptide bonds are observed at Arg-78 and Pro-103. Arg-78 is located in a coil region connecting ␤-strands 6 and 7, whereas Pro-103 is positioned in the loop between ␤-strands 9 and 10. The side chain of Arg-78 points away from the active site cleft.
When crystals of human galactose mutarotase are grown in the presence of D-galactose, the space group changes from P2 1 to P1 with four molecules in the asymmetric unit. These four monomers are, however, virtually identical, such that their ␣-carbons superimpose with r.m.s.d. values between 0.17 and 0.18 Å. The Gly-His motif at the N terminus is visible in the electron density for two of the four monomers in the asymmetric unit. Again, for the sake of simplicity, the following discussion will refer only to monomer I in the P1 asymmetric unit. Within experimental error, there are no significant structural changes in the enzyme that occur upon galactose binding. All main chain plus C-␤ atoms for the apo-and substrate-bound forms of galactose mutarotase correspond with a r.m.s.d. of 0.19 Å. The sugar moiety is situated in a shallow active site cleft with its 3-, 4-, and 6-hydroxyl groups somewhat solventexposed (as shown in Fig. 2b) .
A close-up view of the region surrounding the sugar ligand is depicted in Fig. 3a tween the protein and the ligand is presented in Fig. 3b . As predicted by Timson and Reece (30) , Glu-307 is located within ϳ2.8 Å of the 1-hydroxyl group of galactose and thus is in the proper position to serve as the catalytic base for proton abstraction. Likewise, His-176 lies at ϳ2.8 Å from the ring oxygen and could possibly serve as a catalytic acid. The hydrogen bonding pattern displayed around the galactose moiety in the human enzyme is similar to that observed for the L. lactis mutarotasesugar complex (24) . The notable exceptions, however, are those interactions observed between the sugar and Asn-81 and Gln-279 in the human protein. The structurally equivalent residues in the L. lactis mutarotase are Gly-70 and Val-277, respectively. Recently, the structure of the apo-form of galactose mutarotase from Caenorhabditis elegans was solved to 1.85 Å resolution and the x-ray coordinates deposited in the Protein Data Bank (1LUR; Northeast Structural Genomics Target Wr66). Examination of the model for the C. elegans mutarotase demonstrates that the amino acid residues involved in sugar binding in the human protein, as highlighted in Fig. 3b , are conserved except for the replacement of Gln-279 with a histidine residue. It can thus be postulated that galactose will bind to the C. elegans protein in a similar fashion to that observed for the human and L. lactis enzymes.
The amino acid sequence similarity and identity between the human and L. lactis mutarotases is 49 and 32%, respectively. As expected from such high primary structural homology, these two enzymes have similar overall molecular architectures as shown in Fig. 4a . Indeed, the two mutarotases correspond with a r.m.s.d. of 1.2 Å for 307 structurally equivalent ␣-carbons. There are five regions where the two enzymes do differ significantly, however. As indicated by the letter A in Fig. 4a , there is a six-residue insertion beginning at Glu-11 in the human protein. Another five-residue insertion, starting at Val-45, occurs in the human enzyme and is labeled B in Fig. 4a . Likewise, there are two insertions in the L. lactis versus the human enzyme: a four-residue insertion beginning at Asp-113 (not visible in the view given in Fig. 4a ) and a five-residue insertion starting at Met-233 of the bacterial enzyme, which is labeled C. Strikingly, the region defined by Met-233 to Val-239 in the bacterial protein adopts an ␣-helical motif, which is missing in the human protein. Apart from these insertions/deletions, the polypeptide chains for the two enzymes differ elsewhere in the area delineated by Gln-67 to Phe-72, in the human mutarotase, and Glu-56 to Pro-61, in the L. lactis enzyme, as indicated in Fig. 4a . The differences observed in this region arise from the substitution of Pro-70 and Phe-72 with Ala-59 and Pro-61 in the human and bacterial proteins, respectively. Note that this region of polypeptide chain defines part of the active site cleft.
The mutarotase from C. elegans demonstrates an amino acid sequence identity of 33% with the human protein, and the two eukaryotic proteins superimpose with a r.m.s.d. of 1.0 Å for 301 equivalent ␣-carbons. Perhaps the most striking difference between the human and C. elegans enzymes occurs at the N terminus as can be seen in Fig. 4b . In the C. elegans protein, the first 17 residues are missing, thereby reducing the number of ␤-strands by one. Interestingly, the cis-peptide geometry observed at position 78 of the human enzyme is conserved in the L. lactis enzyme as cis-Pro-67 and as cis-Arg-63 in the C. elegans protein. Furthermore, although Pro-103 in the human enzyme is in the cis conformation, the peptide bonds for the prolines in the equivalent positions in the C. elegans and L. lactis mutarotases are in the trans conformation.
While the maintenance of the anomeric equilibrium of galactose is likely to be a major biochemical role for galactose mutarotase, it may also function in the metabolism of glucose and other sugars. Indeed, mutarotases have been shown to turn over various sugars including D-glucose, D-fucose, D-quinovose, L-arabinose, and D-xylose (8, 23, 33) . With the gene sequence for the human enzyme now known, it will be possible to explore both its pattern of tissue expression and subcellular location. Undoubtedly, further biochemical investigations will shed additional light on the role of this fascinating enzyme in sugar metabolism.
